SMLR vs BEAT vs AEYE vs GXAI vs ATEC

For growth investors, Gaxos.

ai Inc. (GXAI) is the stronger pick with 1473% revenue growth year-over-year, versus -17. 4% for Semler Scientific, Inc. (SMLR). Semler Scientific, Inc. (SMLR) offers the better valuation at 4. 0x trailing P/E, making it the more compelling value choice. Analysts rate Semler Scientific, Inc. (SMLR) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Alphatec Holdings, Inc.

(ATEC) delivered a total return of -48. 7%, compared to -97. 5% for Gaxos. ai Inc. (GXAI). Over 10 years, the gap is even starker: SMLR returned +1110% versus GXAI's -97. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Gaxos.

ai Inc. (GXAI) is the lower-risk stock at 0. 53β versus Semler Scientific, Inc. 's 2. 48β — meaning SMLR is approximately 368% more volatile than GXAI relative to the S&P 500. On balance sheet safety, Semler Scientific, Inc. (SMLR) carries a lower debt/equity ratio of 0% versus 17% for Alphatec Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Gaxos.

ai Inc. (GXAI) is pulling ahead at 1473% versus -17. 4% for Semler Scientific, Inc. (SMLR). On earnings-per-share growth, the picture is similar: Semler Scientific, Inc. grew EPS 95. 1% year-over-year, compared to 15. 0% for Alphatec Holdings, Inc.. Over a 3-year CAGR, ATEC leads at 29. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Semler Scientific, Inc.

(SMLR) is the more profitable company, earning 72. 7% net margin versus -850. 3% for Gaxos. ai Inc. — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMLR leads at 37. 2% versus -919. 7% for GXAI. At the gross margin level — before operating expenses — GXAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ATEC: 222.

6% to $25. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Gaxos.

ai Inc. (GXAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). AudioEye, Inc. (AEYE) carries a higher beta of 2. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GXAI: -97. 5%, AEYE: +102. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SMLR (Healthcare) and BEAT (Healthcare) and AEYE (Technology) and GXAI (Technology) and ATEC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SMLR is a small-cap deep-value stock; BEAT is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; GXAI is a small-cap high-growth stock; ATEC is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.